Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISOPROTERENOL Cause Drug ineffective? 102 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Drug ineffective have been filed in association with ISOPROTERENOL (Isoproterenol Hydrochloride). This represents 32.8% of all adverse event reports for ISOPROTERENOL.

102
Reports of Drug ineffective with ISOPROTERENOL
32.8%
of all ISOPROTERENOL reports
17
Deaths
57
Hospitalizations

How Dangerous Is Drug ineffective From ISOPROTERENOL?

Of the 102 reports, 17 (16.7%) resulted in death, 57 (55.9%) required hospitalization, and 44 (43.1%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISOPROTERENOL. However, 102 reports have been filed with the FAERS database.

What Other Side Effects Does ISOPROTERENOL Cause?

Toxic epidermal necrolysis (56) Off label use (25) Ventricular tachycardia (17) Cardiogenic shock (16) Torsade de pointes (13) Atrial tachycardia (12) Drug ineffective for unapproved indication (12) Bradycardia (11) Overdose (11) Toxicity to various agents (11)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which ISOPROTERENOL Alternatives Have Lower Drug ineffective Risk?

ISOPROTERENOL vs ISOSORBIDE ISOPROTERENOL vs ISOSORBIDE DINITRATE ISOPROTERENOL vs ISOSORBIDE MONONITRATE ISOPROTERENOL vs ISOTRETINOIN ISOPROTERENOL vs ISRADIPINE

Related Pages

ISOPROTERENOL Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective ISOPROTERENOL Demographics